XML 30 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
 9 Months Ended
Sep. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events

(12)

Subsequent Events  

Termination of Agreement with medac

On October 12, 2021, the Company notified medac in writing that it was terminating the License Agreement, with the effective

date of termination of the License Agreement stipulated as April 12, 2022, due to medac’s nonpayment of the FOCUS trial

efficacy milestone. In a letter dated October 27, 2021, medac notified the Company that it disputed the Company’s right to terminate the License Agreement and threatened to claim damages from the Company should it fail to withdraw its notice of termination of the License Agreement. The License Agreement stipulates that disputes between the parties are to be handled via

binding arbitration. Communication between the Company and medac is ongoing and at the time of the filing neither party has initiated arbitration.